Chiang Mai Ram Medical Business Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Chiang Mai Ram Medical Business has been growing earnings at an average annual rate of 9.8%, while the Healthcare industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 8.3% per year. Chiang Mai Ram Medical Business's return on equity is 6.8%, and it has net margins of 5.2%.
Belangrijke informatie
9.8%
Groei van de winst
9.7%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 23.6% |
| Inkomstengroei | 8.3% |
| Rendement op eigen vermogen | 6.8% |
| Nettomarge | 5.2% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Chiang Mai Ram Medical Business geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 5,345 | 279 | 726 | 0 |
| 31 Mar 24 | 5,243 | 242 | 731 | 0 |
| 31 Dec 23 | 5,144 | 218 | 712 | 0 |
| 30 Sep 23 | 4,980 | 160 | 713 | 0 |
| 30 Jun 23 | 4,906 | 187 | 681 | 0 |
| 31 Mar 23 | 5,242 | 453 | 663 | 0 |
| 31 Dec 22 | 5,269 | 504 | 658 | 0 |
| 30 Sep 22 | 5,475 | 577 | 621 | 0 |
| 30 Jun 22 | 5,210 | 564 | 590 | 0 |
| 31 Mar 22 | 4,575 | 326 | 558 | 0 |
| 31 Dec 21 | 4,244 | 292 | 529 | 0 |
| 30 Sep 21 | 3,858 | 258 | 523 | 0 |
| 30 Jun 21 | 3,742 | 211 | 520 | 0 |
| 31 Mar 21 | 3,634 | 182 | 527 | 0 |
| 31 Dec 20 | 3,717 | 198 | 537 | 0 |
| 30 Sep 20 | 3,758 | 201 | 540 | 0 |
| 30 Jun 20 | 3,847 | 170 | 535 | 0 |
| 31 Mar 20 | 4,070 | 247 | 536 | 0 |
| 31 Dec 19 | 3,965 | 158 | 535 | 0 |
| 30 Sep 19 | 3,924 | 181 | 530 | 0 |
| 30 Jun 19 | 3,906 | 247 | 524 | 0 |
| 31 Mar 19 | 3,871 | 271 | 516 | 0 |
| 31 Dec 18 | 3,969 | 375 | 512 | 0 |
| 30 Sep 18 | 3,961 | 414 | 488 | 0 |
| 30 Jun 18 | 4,020 | 489 | 498 | 0 |
| 31 Mar 18 | 3,929 | 481 | 487 | 0 |
| 31 Dec 17 | 3,775 | 440 | 487 | 0 |
| 30 Sep 17 | 3,719 | 422 | 503 | 0 |
| 30 Jun 17 | 3,603 | 404 | 479 | 0 |
| 31 Mar 17 | 3,534 | 366 | 481 | 0 |
| 31 Dec 16 | 3,505 | 388 | 471 | 0 |
| 30 Sep 16 | 3,437 | 386 | 464 | 0 |
| 30 Jun 16 | 3,389 | 402 | 453 | 0 |
| 31 Mar 16 | 3,295 | 433 | 423 | 0 |
| 31 Dec 15 | 3,314 | 501 | 399 | 0 |
| 30 Sep 15 | 3,222 | 509 | 368 | 0 |
| 30 Jun 15 | 3,081 | 445 | 368 | 0 |
| 31 Mar 15 | 3,025 | 437 | 358 | 0 |
| 31 Dec 14 | 2,922 | 387 | 352 | 0 |
| 30 Sep 14 | 2,849 | 379 | 356 | 0 |
| 30 Jun 14 | 2,908 | 449 | 336 | 0 |
| 31 Mar 14 | 2,829 | 429 | 313 | 0 |
| 31 Dec 13 | 2,676 | 367 | 307 | 0 |
Kwaliteitswinsten: CMR-R has high quality earnings.
Groeiende winstmarge: CMR-R's current net profit margins (5.2%) are higher than last year (3.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CMR-R's earnings have grown by 9.8% per year over the past 5 years.
Versnelling van de groei: CMR-R's earnings growth over the past year (49.2%) exceeds its 5-year average (9.8% per year).
Winst versus industrie: CMR-R earnings growth over the past year (49.2%) exceeded the Healthcare industry 16.7%.
Rendement op eigen vermogen
Hoge ROE: CMR-R's Return on Equity (6.8%) is considered low.